Dharma Centro de Medicina Regenerativa
Rosario, Santa Fe Province, 2000, Argentina
NCT Number: NCT05416255
Participants with grade 3 and 4 knee osteoarthritis will recieve aspiration of synoivial fluid, and then receive either dextrose, hemaotopoietic stem cell, or platelet rich plasma, or no injection. The synovial fluid will be analyzed for changes in components.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Rosario, Santa Fe Province, 2000, Argentina
80 participants with grade 3 and 4 symptomatic knee osteoarthritis, with a visable effusion, will receive aspiration of 3 ml of synovial fluid from the suprapatellar pouch, followed by either injection with 10 mL of 12.5% dextrose, 10 cc hematopoietic stem cells, 10cc PRP, or no injection into the suprapatellar pouch. They will then receive aspiration of 3 ml of synovial fluid at 2 days and either 7 days (for dextrose injected or no injection) or 14 days (stem cell and PRP injected) days post injection. These synovial samples will be analyzed for a change in components.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
≥ 6 months of knee pain with walking
Exclusion criteria
Using speialized techniques to measure S.F. components
Time frame: Day 0 to Day 14
Change in level of unspecified synovial fluid components from Day 0 to 7 or Day 0 to 14, depending on group
Time frame: Day 0 to Day 14
Change in WOMAC score from Day 0 to Day 14
Time frame: Day to Day 14
Change in NRS pain score from Day 0 to Day 14
Dharma Bioscience
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05603754
Arthritis, Joint Diseases
Tucson, Arizona, United States
View Trial DetailsNCT05730829
Arthritis, Joint Diseases
Hamilton, Ontario, Canada
View Trial DetailsNCT07790146
Arthritis, Joint Diseases
Samara, Samara Oblast, Russia
View Trial DetailsNCT06766877
Arthritis, Joint Diseases
Karachi, Sindh, Pakistan
View Trial Details